Skip to main content

Vanderbilt Research Trending Archives

New target to stop Ebola

May. 21, 2018—A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.

Read more


Deerfield Management, Vanderbilt University announce launch of Ancora Innovation

Mar. 28, 2018—Deerfield Management and Vanderbilt University announced March 28 the launch of Ancora Innovation, LLC (“Ancora”), a Deerfield company that will support Vanderbilt’s innovative life science research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development.

Read more


Nine new endowed chair recipients honored

Mar. 5, 2018—Nine Vanderbilt University faculty members named to endowed chairs were honored during a celebration at the Student Life Center Feb. 28.

Read more


Saline use on decline at Vanderbilt following landmark studies

Feb. 27, 2018—Vanderbilt University Medical Center is encouraging its medical providers to stop using saline as intravenous fluid therapy for most patients, a change provoked by two companion landmark studies released Feb. 27 that are anticipated to improve survival and decrease kidney complications.

Read more


Opioid use increases risk of serious infections

Feb. 12, 2018—Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don’t use opioids.

Read more


‘Smart cane’ could one day help flag gait problems, falling risks more quickly

Feb. 12, 2018—Falling is no joke when you're a senior citizen or have other balance issues. Vanderbilt engineers are working on a 'smart cane' that could help physical therapists spot and treat problems sooner.

Read more


Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment

Jan. 8, 2018—Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia.

Read more


Study seeks to reduce opioid use for chronic pain

Nov. 30, 2017—Kristin Archer, PhD, DPT, associate professor and vice chair of Orthopaedics and Rehabilitation, will serve as principal investigator at Vanderbilt University Medical Center (VUMC) for a clinical trial that is examining strategies for reducing opioid use among patients with chronic pain.

Read more


‘Mind’s eye blink’ proves ‘paying attention’ is not just a figure of speech

Nov. 21, 2017—Vanderbilt psychologists have discovered that when you shift your attention from one place to another, your brain 'blinks'—or experiences momentary gaps in perception.

Read more


15 faculty members elected as AAAS fellows

Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.

Read more


Vanderbilt leads international effort to develop universal flu vaccine

Oct. 26, 2017—Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.

Read more


Cell signals that trigger wound healing are surprisingly complex

Oct. 3, 2017—Vanderbilt scientists have taken an important step toward understanding the way in which injured cells trigger wound healing, an insight essential for improving treatments of all types of wounds.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more